Search
for
Sort by
Research 91–120 of 1000+
- Drug-Induced Skin, Nail and Hair Disorders
- Mucocutaneous reactions to chemotherapy
- Exploring the Versatility of Microemulsions in Cutaneous Drug Delivery: Opportunities and Challenges
- Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions—A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data
- KRDQN: An Interpretable Prediction Framework for Adverse Drug Reactions via Knowledge–Graph Reinforced Deep Q-Learning
- Successful treatment with hydroxychloroquine for systemic lupus erythematosus with cutaneous involvement accompanied by a xanthomatous reaction
- Erythematous cutaneous nodules caused by adulterated cocaine
- Cutaneous lupus erythematosus. Diagnostic and therapeutic recommendations of the Polish Dermatological Society
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Epithelial–mesenchymal transition in cutaneous fibrosis disease: from mechanisms to therapy
- Acneiform Rash Caused by an Unlikely Drug: Topiramate
- Incidence and management of cutaneous toxicities associated with cetuximab
- Hair loss after drug reaction with eosinophilia and systemic symptoms (DRESS): A multicentric retrospective case series
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- 85 Primary cutaneous follicle center lymphoma spans yet unrecognised subtypes including polyclonal reactions
- Viral reactivation in hospitalized patients with drug reaction with eosinophilia and systemic symptoms: A retrospective study from a tertiary medical center in the United States
- Systemic Vasculitis with Severe Cutaneous Manifestation as a Suspected Idiosyncratic Hypersensitivity Reaction to Fenbendazole in a Cat
- Novel Strategies for Androgenetic Alopecia Therapy: Integrating Multifunctional Plant Extracts with Nanotechnology for Advanced Cutaneous Drug Delivery
- Cutaneous manifestations associated with substance use disorders
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Severe hair loss associated with psyc hotropic drugs in psychiatric inpatients—Data from an observational pharmacovigilance program in German-speaking countries
- Microneedles as transdermal drug delivery system for enhancing skin disease treatment
- Semaglutide and the Skin: An Overview of Current Evidence
- 572 Development of immunotherapies targeting TCR-Vβ2 for treatment of cutaneous T cell lymphoma
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Dermatological adverse events with taxane chemotherapy
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts